II-VI Inc. (IIVI) Tops Q3 EPS Views; Guides Q4, FY11 Above Street Views
Tweet
Share
E-mailGet Alerts IIVI Hot Sheet
Price: $41.95 --0%
Financial Fact:
Selling, general and administrative: 42.08M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Selling, general and administrative: 42.08M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
II-VI Inc. (Nasdaq: IIVI) reported Q3 EPS of $0.72, $0.19 better than the analyst estimate of $0.53. Revenue for the quarter came in at $130 million versus the consensus estimate of $121.07 million.
Sees Q411 EPS of $0.68 - $0.73, versus the consensus of $0.57. Also sees Q411 revenue of $129 - $134 million, versus the consensus of $129.52 million.
Sees FY11 EPS of $2.58 - $2.63, versus the consensus of $2.29. Also sees FY11 revenue of $500 - $505 million, versus the consensus of $489.63 million.
Sees Q411 EPS of $0.68 - $0.73, versus the consensus of $0.57. Also sees Q411 revenue of $129 - $134 million, versus the consensus of $129.52 million.
Sees FY11 EPS of $2.58 - $2.63, versus the consensus of $2.29. Also sees FY11 revenue of $500 - $505 million, versus the consensus of $489.63 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
